Isidakamizwa esishintsha umdlalo we-hepatitis C, iSovaldi (sofosbuvir) , sahlaselwa ekuqaleni kuka-2014 lapho kumenyezelwa ukuthi inani lentengo ye-course yezinyanga ezingu-12 laliyi-$ 84,000, noma imali engamaRandi ayi-1 000. Nakuba imizamo eyenziwe ngumenzi, i-Sciences eGileyadi ukuhlinzeka ukufinyelela kumazwe ompofu kanye nabantu ngabanye, izindleko eziphezulu zalesi sidakamizwa zifaka ingcindezi ngisho nalabo abanempilo enhle, izindleko ezingaphandle kwezezimali zivame ukukhuphuka ezinkulungwaneni amadola.
Lezi zindaba ziphinde ziphinde ziphinde zibonise izindleko eziphezulu zezidakamizwa ezisetshenziselwa ukwelashwa kwesifo sofuba e-US Njengoba kunezigidi ezingu-3.2 zabantu baseMelika abanesifo sofuba esibhedlela i-hepatitis C (HCV) kanye nabangaphezu kwezigidi ezimbili abanesandulela ngculazi nge-hepatitis B (HBV), isidingo sokuthola izidakamizwa ezingabizi akukaze kube mkhulu.
Ngaphezu kwalokho, kusukela kumbono womhlaba jikelele, phakathi kwabantu abayizigidi eziyisihlanu kuya kwezihlanu banesandulela-ngculazi ne-HCV emhlabeni wonke (noma cishe 9% o-HIV).
Uhlelo lwe-Co-Pay kanye ne-Patient Assistance Program (PAP) Ukufaneleka
Emzamweni wokuqinisekisa ukufinyeleleka okungabizi, i-Fair Pricing Coalition (FPC) ixoxisane nezinhlelo zokusiza ngokukhokhela ama-co-pay kanye nama-patient (PAPs) kakhulu kunabo bonke abakhiqizi bezidakamizwa ze-hepatitis. Zombili izinhlelo zinikeza usizo ezigulini ezihlangabezana nemigomo yokufaneleka, esekelwe ekutholeni umndeni wamakhaya noma kwiNational Level Poverty Level (noma iFPL). I-criteria yokufakwa ihlukahluka ngohlelo, ngamanye ama-PAP, isibonelo, ukuhlinzeka ukufinyelela kulabo abanenzuzo engaphansi kuka-500% we-FPL.
Inani le-FPL okwamanje elisetshenziselwa ukuhlolwa kokufaneleka liyatholakala kwiwebhusayithi ye-Health.gov.
Ngenkathi izinhlelo zokukhokha ngokubambisana zisiza ngokukhokhwa kwemali yomshuwalense womuthi ngamunye, ama-PAP asebenza ngokuhlinzeka ngemali ephansi yokuthola imithi yamahhala kubantu abafanelekile. Ukuqinisekiswa kwemali engenayo kuyadingeka, ngokuvamile ngendlela yokubuyisela intela yentela yombuso.
Ukuthuthukiswa okwakamuva kwakungukusungulwa kohlelo oluvamile lwe-PAP, isinyathelo esilungiswa ngohulumeni wase-US ukuze kulungiswe inqubo yesicelo. Ifomu eligcwalisiwe kuzodingeka lihanjiswe ohlelweni losizo lomuthi ngamunye wokucubungula.
| Isidakamizwa | Inkampani | Othintana naye | Uhlobo lohlelo | Imininingwane Yezinhlelo |
| I-Copegus (ribavirin) | Genentech / Roche | 888-941-3331 noma uvakashele iwebhusayithi ye-Pegasys Access | I-PAP | Ihlanganisa abantu abangafaneleki nganoma yimuphi omunye usizo. Ukufaneleka kulinganiselwe ngemali engenayo. |
| I-Daklinza | I-Bristol-Myers Squibb | 844-442-6663 noma Usizo lwe-BMS lwezokusekela CONNECT | Co-Pay | Ifinyelela ku-$ 5,000 ngezinhlinzeko zezinsuku ezingu-28. |
| I-Bristol-Myers Squibb | 800-736-0003 noma iBS Patient Assistance Foundation | I-PAP | Ihlanganisa abantu abangafanelekeli ukuthola olunye usizo olungenayo imali engaphansi kuka-250% we-FPL. | |
| I-Epclusa | I-Sciences yaseGileyadi | 855-769-7284 noma iwebhusayithi ye-Gilead Support Path | Co-Pay | Iyancipha izindleko zokukhokha ngokubambisana njengama-$ 5 eziguli ezifanelekayo ezingenayo imali engaphansi kuka-$ 100,000 emndenini wezingane ezintathu noma ngaphansi kuka-500% we-FPL emndenini wezine noma ngaphezulu. |
| I-Sciences yaseGileyadi | 855-769-7284 noma iwebhusayithi ye-Gilead Support Path | I-PAP | Inganikeza ukuhlinzeka mahhala kweziguli ezingenayo imali engaphansi kuka-$ 100,000 emndenini wezingane ezintathu noma ngaphansi kuka-500% we-FPL emndenini wezine noma ngaphezulu. | |
| Harvoni | I-Sciences yaseGileyadi | 855-769-7284 noma iwebhusayithi ye-Gilead Support Path | Co-Pay | Iyancipha izindleko zokukhokha ngokubambisana njengama-$ 5 eziguli ezifanelekayo ezingenayo imali engaphansi kuka-$ 100,000 emndenini wezingane ezintathu noma ngaphansi kuka-500% we-FPL emndenini wezine noma ngaphezulu. |
| I-Sciences yaseGileyadi | 855-769-7284 noma iwebhusayithi ye-Gilead Support Path | I-PAP | Inganikeza ukuhlinzeka mahhala kweziguli ezingenayo imali engaphansi kuka-$ 100,000 emndenini wezingane ezintathu ezingaphansi kwama-500% we-FPL emndenini wezine noma ngaphezulu. | |
| I-Olysio | I-Janssen Therapeutics | 855-5-OLYSIO noma iwebhusayithi yomkhiqizo | Co-Pay | Iyancipha ukukhokhela ngokukhokha okungaphezulu kwe $ 5 ngenyanga. Imali engenayo yemindeni kumele ibe ngaphansi kuka-500% we-FPL. |
| I-Janssen Therapeutics | 800-652-6227 noma uJohnson & Johnson Patient Assistance Foundation | I-PAP | Inikeza ukukhokhelwa mahhala kuka-Olysio kubantu abaqeqeshiwe abahola imali engaphansi kwe-500% ye-FPL. | |
| Genentech / Roche | 888-941-3331 noma uvakashele iwebhusayithi ye-Pegasys Access | I-PAP | Ihlanganisa abantu abangafaneleki nganoma yimuphi omunye usizo. Ukufaneleka kulinganiselwe ngemali engenayo. | |
| I-PegIntron (i-peginterferon) | Merck | 866-939-4372 noma iwebhusayithi yomkhiqizo | Co-Pay | Inikeza iziguli ezifanelekile kuze kufinyelele ku-$ 200 imali ukuze kube nemigomo engu-12. |
| Merck | 866-363-6379 noma iwebhusayithi ye-Merck isiza | I-PAP | Ihlanganisa abantu abangafaneleki nganoma yimuphi omunye usizo. Ukufaneleka kulinganiselwe ngemali engenayo (ngokuvamile imali engenayo yasemakhaya engaphansi kwama-500% we-FPL). | |
| I-Sovaldi | I-Sciences yaseGileyadi | 855-769-7284 noma iwebhusayithi ye-Gilead Support Path | Co-Pay | Iyancipha izindleko zokukhokha ngokubambisana njengama-$ 5 eziguli ezifanelekayo ezingenayo imali engaphansi kuka-$ 100,000 emndenini wezingane ezintathu noma ngaphansi kuka-500% we-FPL emndenini wezine noma ngaphezulu. |
| I-Sciences yaseGileyadi | 855-769-7284 noma iwebhusayithi ye-Gilead Support Path | I-PAP | Inganikeza ukuhlinzeka mahhala kweziguli ezingenayo imali engaphansi kuka-$ 100,000 emndenini wezingane ezintathu noma ngaphansi kuka-500% we-FPL emndenini wezine noma ngaphezulu. | |
| Viekira Pak | Abbvie | 844-2PROCEED (844-277-6233) noma iwebhusayithi ye-Abbvie ProCeed | Co-Pay | Iziguli zingase zivumeleke ukuba zikhokhele u-95% okhokhelwayo ngokukhokha. |
| Abbvie | 844-2PROCEED (844-277-6233) noma iwebhusayithi ye-Abbvie ProCeed | I-PAP | Inganikeza ukuhlinzeka mahhala kweziguli ezingenayo imali engaphansi kuka-$ 100,000 emndenini wezingane ezintathu noma ngaphansi kuka-500% we-FPL emndenini wezine noma ngaphezulu. | |
| I-Zepatier | Merck | 866-251-6013 noma iwebhusayithi ye-Merck Access | Co-Pay | Iyanciphisa izindleko zokukhokha ngokubambisana njengezinga eliphansi njenge $ 5 ngenyanga ngenyanga yeziguli ezifanelekayo. |
| Merck | 866-251-6013 noma iwebhusayithi ye-Merck Access | I-PAP | Inganikeza ukuhlinzeka mahhala kweziguli ezingenayo imali engu-$ 59,400 noma ngaphezulu kubantu, $ 80,100 noma ngaphansi kumibhangqwana, noma i-$ 121,500 noma ngaphansi komndeni wezingu-4 noma ngaphezulu. |
Imithombo:
Sanger-Katz, M. "$ 1,000 I-Hepatitis Pill Ibonisa ukuthi kungani Ukulungisa Izindleko Zempilo Kunzima Kakhulu." I-New York Times; ishicilelwe ngo-Agasti 2, 2014.
U-Rotman, Y. noLiang, T. "Ukufakelwa kwe-Coinfection ne-Hepatitis C Virus ne-Human Immunodeficiency Virus: Imithi Ye-Virological, Immunological, kanye Nemitholampilo." Journal of Virology. Agasti 2009; 83 (15): 7366-7374.
Lungisa, O .; Locarnini, S .; kanye noPeters, M. "Virology And Clinical Management ye-Hepatitis B ne-HIV Coinfection." I-PRN Notebook. Ephreli 2007; ivolumu 11.